A new study released in the journal, Nature, evaluated a newer approach to treating metastatic prostate cancer through Integrating chemo hormonal therapy and surgery. The method was applied to known or suspected lymph node metastatic prostate cancer.
Read MoreThe Dana-Farber Cancer Institute reported by the Stand Up To Cancer-Prostate Cancer Foundation Dream Team published a new study in the journal, Cell. The findings target a potential new drug therapy for treating prostate cancer. It's the first study of the genomic composition of prostate cancer.
Read MoreThere has been much controversy as to whether or not cycling has an effect on PSA or the emergence of prostate cancer. Although there have been many contradictory studies, overall it seems that riding your bike does not increase your risk for prostate cancer.
Read MoreWhy is this important? Because prostate cancer is to men as breast cancer is to women. And just as with any other cancer, an early understanding of your risk factors and how to potentially reduce them is tremendously valuable. We explore.
Read More
Could obesity be to blame for the higher rates of prostate cancer in African American men? According to a new study from the University Of Washington School Of Nursing and the Fred Hutchinson Cancer Research Center in Seattle – yes, obesity might play a role.
Read MoreThis year at the 110th Annual Scientific Meeting of the American Urological Association (AUA), four new studies will be presented which examine different approaches to what researchers believe are smarter methods to screen for prostate cancer.
Controversy remains surrounding the use of the PSA test to screen for prostate cancer. This is due to the belief that the PSA test may lead to over-diagnosis and over-treatment in men with low-grade, less aggressive forms of the disease. Clinicians have been long awaiting a new approach to screen for prostate cancer because the current PSA test is simply not accurate enough.
Read MoreJohnathan Watkins of King's College London published the first ever study analyzing the health effects of unemployment related to prostate cancer in the journal, eCancerMedicalScience — an open access journal from the European Institute of Oncology.
Read MoreHormone therapy, or androgen deprivation therapy (ADT), is used to suppress a man’s testosterone level in hopes of starving the prostate cancer tumor. But what are the risks?
Read MoreNew research from Dana-Farber Cancer Institute in Boston suggests that statins may help slow the growth of prostate cancer in patients receiving hormone therapy. Here's what men need to know.
Read MoreMen with prostate cancer, getting treated with ADT (androgen deprivation therapy) may be at risk for cognitive impairment.
Read MoreMen diagnosed with both conditions have significantly reduced chances of survival. Emotions of pity, powerlessness, and other indications of depression are commonplace and reasonable in someone who has been diagnosed with prostate cancer.
Read More
